APPRISE COVID-19 publications and presentations
APPRISE researchers have co-authored or presented the following publications and presentations related to the COVID-19 pandemic
- Optimal allocation of PCR tests to minimise disease transmission through contact tracing and quarantine
- Doherty Modelling Interim Report to National Cabinet 17th September 2021
- Therapeutic anticoagulation with heparin in critically ill patients with Covid-19
- Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19
- Doherty Modelling Report Revised 10th August 2021
- Doherty Modelling Report for National Cabinet 30 July 2021
- Leading with local solutions to keep Yarrabah safe: a grounded theory study of an Aboriginal community-controlled health organisation’s response to COVID-19
- The impact of the COVID‐19 pandemic on routine vaccinations in Victoria
- Australia needs a prioritised national research strategy for clinical trials in a pandemic: lessons learned from COVID-19
- Reprogrammed CRISPR-Cas13b suppresses SARS-CoV-2 replication and circumvents its mutational escape through mismatch tolerance
- An increased ratio of SARS-CoV-2 positive to negative sense genomic and subgenomic RNAs within routine diagnostic upper respiratory tract swabs may be a marker of virion shedding [preprint]
- Whole of population-based cohort study of recovery time from COVID-19 in New South Wales Australia
- Temporal differences in culturable severe acute respiratory coronavirus virus 2 (SARS-CoV-2) from the respiratory and gastrointestinal tracts in a patient with moderate coronavirus disease 2019 (COVID-19)
- Evaluation of 6 commercial SARS-CoV-2 serology assays detecting different antibodies for clinical testing and serosurveillance
- COVID‐19 Real‐time Information System for Preparedness and Epidemic Response (CRISPER)
- Multi-site assessment of rapid, point-of-care antigen testing for the diagnosis of SARS-CoV-2 infection in a low-prevalence setting: A validation and implementation study
- Integrated immune dynamics define correlates of COVID-19 severity and antibody responses
- Interleukin-6 receptor antagonists in critically ill patients with Covid-19
- Value of consultation in establishing a public health research network: lessons from APPRISE
- Education and training in infection prevention and control: Exploring support for national standards
- How should we conduct pandemic vaccination?
- Constructing an ethical framework for priority allocation of pandemic vaccines
- How do data bolster pandemic preparedness and response? How do we improve data and systems to be better prepared?
- Hospital outcomes after a COVID-19 diagnosis from January to May 2020 in New South Wales Australia
- Outcomes for patients with COVID‐19 admitted to Australian intensive care units during the first four months of the pandemic
- Priority allocation of pandemic influenza vaccines in Australia – Recommendations of 3 community juries.
- Maintaining strong foundations and building resilience: planning Australia’s path through the COVID-19 pandemic
- Where has all the influenza gone? The impact of COVID-19 on the circulation of influenza and other respiratory viruses, Australia, March to September 2020
- COVID-19 public health measures and respiratory syncytial virus
- SARS-CoV-2 genomic and subgenomic RNAs in diagnostic samples are not an indicator of active replication
- Changes in public preferences for technologically enhanced surveillance following the COVID-19 pandemic: a discrete choice experiment
- Seroprevalence of SARS-CoV-2-specific antibodies in Sydney, Australia following the first epidemic wave in 2020
- Ending COVID-19: progress and gaps in research—highlights of the July 2020 GloPID-R COVID-19 Research Synergies Meetings
- Leveraging the advances in HIV for COVID-19
- Coronavirus disease model to inform transmission reducing measures and health system preparedness, Australia
- COVID‐19 in a Sydney nursing home: a case study and lessons learnt
- Effect of hydrocortisone on mortality and organ support in patients with severe COVID-19. The REMAP-CAP COVID-19 corticosteroid domain randomized clinical trial
- Tracking the COVID-19 pandemic in Australia using genomics
- Building an ethics framework for COVID-19 resource allocation: The How and the Why
- An ethics framework for making resource allocation decisions within clinical care: Responding to COVID-19
- Transmission of SARS-CoV-2 in Australian educational settings: a prospective cohort study
- RDA COVID-19 Working Group recommendations and guidelines on data sharing
- Webinar: Bioethics and COVID-19
- The challenges of establishing adequate capacity for SARS‐CoV‐2 testing
- Isolation and rapid sharing of the 2019 novel coronavirus (SARS ‐CoV‐2) from the first patient diagnosed with COVID ‐19 in Australia
- Rapid research report – The most promising therapeutics for COVID-19
- Trajectories of hospital infection control: Using non-representational theory to understand and improve infection prevention and control
- Estimating temporal variation in transmission of COVID-19 and adherence to social distancing measures in Australia [technical report]
- Key ethical concepts and their application to COVID-19 research
- First Nations people leading the way in COVID-19 pandemic planning, response and management
- Estimating the case detection rate and temporal variation in transmission of COVID-19 in Australia [technical report]
- Modelling the impact of COVID-19 in Australia to inform transmission reducing measures and health system preparedness [pre-print]
- Early analysis of the Australian COVID-19 epidemic
- Early analysis of the Australian COVID-19 epidemic [pre-print]
- Assessing the risk of spread of COVID-19 to the Asia Pacific region
- SARS, MERS and COVID-19—new threats; old lessons
- Living with COVID-19: Planning policy for the next stage
- Infectious disease pandemic planning and response: Incorporating decision analysis
- An ethics framework for making resource allocation decisions within clinical care: Responding to COVID-19
- Breadth of concomitant immune responses prior to patient recovery: a case report of non-severe COVID-19